Loading...
Search Filters
Date Range
toReport Types
Condition
See all (5)
Region of the Body
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 6 of 6
Zoledronic acid reduces number of skeletal-related events in new multiple myeloma patients
Lancet Oncol. 2011 Aug;12(8):743-52. doi: 10.1016/S1470-2045(11)70157-7. Epub 2011 Jul 21
Percutaneous vertebroplasty improves spinal stability in patients with multiple myolema
Eur Spine J. 2012 May;21(5):912-9. Epub 2011 Dec 16.
Denosumab noninferior to zoledronic acid in the treatment of bone metastasis
J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22
Reduction in Odds of Pathological Fracture with Denosumab vs Zoledronic Acid for Bone Metastases
J Am Acad Orthop Surg Glob Res Rev. 2020 Aug-01;():. 10.5435/JAAOSGlobal-D-20-00045
Balloon kyphoplasty more effective than non-surgical treatment in cancer patients with VCF
Lancet Oncol. 2011 Mar;12(3):225-35. doi: 10.1016/S1470-2045(11)70008-0. Epub 2011 Feb 16
Significant blood loss during spinal tumour surgery &surgery for metastatic spinal disease
Bone Joint J. 2013 May;95-B(5):683-8. doi: 10.1302/0301-620X.95B5.31270
Showing 1 - 6 of 6